Plasma dependent reduction in red blood cell aggregation after dextran sulfate low-density lipoprotein apheresis - Implications for rheological studies

Therapeutic Apheresis and Dialysis

Volumn 9, Issue 5, 2005, Pages 379-384

  Schechner, Vered ^a,c   Ben Ami, Ronen ^b,c   Hershcovici, Tiberiu ^a,c   Yedgar, Shaul ^d   Beigel, Ytzhak ^a,c   Shapira, Itzhak ^b,c   Berliner, Shlomo ^b,c   Barsthein, Gershon ^d  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Erythrocyte aggregation; Low density lipoprotein apheresis; Plasma

Indexed keywords

DEXTRAN SULFATE; LOW DENSITY LIPOPROTEIN;

APHERESIS; ARTICLE; BLOOD RHEOLOGY; CHEMICAL COMPOSITION; CLINICAL ARTICLE; ERYTHROCYTE AGGREGATION; ERYTHROCYTE MEMBRANE; ERYTHROCYTE SEDIMENTATION RATE; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HUMAN; ISRAEL; LOW DENSITY LIPOPROTEIN APHERESIS; MALE; MICROCIRCULATION; PLASMA; PRIORITY JOURNAL; STANDARD; BLOOD; CELL AGGREGATION; DRUG EFFECT; ERYTHROCYTE; FLOW KINETICS; HYPERCHOLESTEROLEMIA; METHODOLOGY; PHYSIOLOGY;

BLOOD COMPONENT REMOVAL; CELL AGGREGATION; DEXTRAN SULFATE; ERYTHROCYTES; HUMANS; HYPERCHOLESTEROLEMIA; LIPOPROTEINS, LDL; PLASMA; RHEOLOGY;

EID: 33645453017     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2005.00317.x     Document Type: Article

References (39)

1. Martinez M Vaya A Gil L Marti R Dalmau J Aznar J. The cholesterol/phospholipid ratio of the erythrocyte membrane in children with familial hypercholesterolemia. Its relationship with plasma lipids and red blood cell aggregability. Clin Hemorheol Microcirc 1998 18 : 259 63.
2. Soutani M Suzuki Y Tateishi N Maeda N. Quantitative evaluation of flow dynamics of erythrocytes in microvessels: influence of erythrocyte aggregation. Am J Physiol 1995 268 : H1959 H1965.
3. Cabel M Meiselman HJ Popel AS Johnson PC. Contribution of red blood cell aggregation to venous vascular resistance in skeletal muscle. Am J Physiol 1997 272 : H1020 H1032.
4. Cicha I Suzuki Y Tateishi N Maeda N. Changes of RBC aggregation in oxygenation-deoxygenation: pH dependency and cell morphology. Am J Physiol Heart Circ Physiol 2003 284 : H2335 H2342.
5. Bishop JJ Nance PR Popel AS Intaglietta M Johnson PC. Relationship between erythrocyte aggregate size and flow rate in skeletal muscle venules. Am J Physiol Heart Circ Physiol 2004 286 : H113 H120.
6. Yalcin O Uyuklu M Armstrong JK Meiselman HJ Baskurt OK. Graded alterations of RBC aggregation influence in vivo blood flow resistance. Am J Physiol Heart Circ Physiol 2004 287 : H2644 H2650.
7. Kim S Popel AS Intaglietta M Johnson PC. Aggregate formation of erythrocytes in postcapillary venules. Am J Physiol Heart Circ Physiol 2005 288 : H584 H590.
8. Schmid-Schonbein H. Blood rheology and physiology of microcirculation. Ric Clin Lab 1981 11 : 13 33.
9. 2-permeable tube: effects of erythrocyte aggregation. Am J Physiol Heart Circ Physiol 2001 281 : H448 H456.
10. Tateishi N Suzuki Y Shirai M Cicha I Maeda N. Reduced oxygen release from erythrocytes by the acceleration-induced flow shift, observed in an oxygen-permeable narrow tube. J Biomech 2002 35 : 1241 51.
11. Baskurt OK Yalcin O Ozdem S Armstrong JK Meiselman HJ. Modulation of endothelial nitric oxide synthase expression by red blood cell aggregation. Am J Physiol Heart Circ Physiol 2004 286 : H222 H229.
12. Skalak R Zarda PR Jan KM Chien S. Mechanics of Rouleau formation. Biophys J 1981 35 : 771 81.
13. Snabre P Bitbol M Mills P. Cell disaggregation behavior in shear flow. Biophys J 1987 51 : 795 807.
14. Nash GB Wenby R Sowemimo-Coker SO Meiselman HJ. Influence of cellular properties on red cell aggregation. Clin Hemorheol 1987 7 : 93 108.
15. Hadengue A Razavian SM Del Pino M Simon A Levenson J. Influence of sialic acid on erythrocyte aggregation in hypercholesterolemia. Thromb Haemost 1996 76 : 944 9.
16. Beigel Y Fuchs J Snir M Green P Lurie Y Djaldetti M. Lovastatin therapy in hypercholesterolemia: effect on fibrinogen, hemorrheologic parameters, platelet activity, and red blood cell morphology. J Clin Pharmacol 1991 31 : 512 17.
17. Jaeger BR. Evidence for maximal treatment of atherosclerosis: drastic reduction of cholesterol and fibrinogen restores vascular homeostasis. Ther Apher 2001 5 : 207 11.
18. Otto C Geiss HC Laubach E Schwandt P. Effects of direct adsorption of lipoproteins apheresis on lipoproteins, low-density lipoprotein subtypes, and hemorheology in hypercholesterolemic patients with coronary artery disease. Ther Apher 2002 6 : 130 5.
19. Bosch T Wendel T Jaeger BR Samtleben W. Improvement of Hemorheology by DALI Apheresis: Acute Effects on Plasma Viscosity and Erythrocyte Aggregation in Hypercholesrolemic Patients. Ther Apher 2001 5 : 372 6.
20. Kulschar R Engelmann B Brautigam C Duhm J Thiery J Richter WO. Fast transmission of alterations in plasma phosphatidylcholine/sphingomyelin ratio and lyso phosphatidylcholine levels into changes of red blood cell membrane phospholipid composition after low density lipoprotein apheresis. Eur J Clin Invest 1995 25 : 258 65.
21. Engelmann B Brautigam C Kulschar R et al. Reversible reduction of phospholipid bound arachidonic acid after low density lipoprotein apheresis. Evidence for rapid incorporation of plasmalogen phosphatidylethanolamine into the red blood cell membrane. Biochim Biophys Acta 1994 1196 : 154 64.
22. Schechner V Shapira I Berliner S et al. Significant dominance of fibrinogen over immunoglobulins, C-reactive protein, cholesterol and triglycerides in maintaining increased red blood cell adhesiveness/aggregation: a model in hypercholaesterolemic patients. Eur J Clin Invest 2003 33 : 955 61.
23. Hershcovici T Elishkevitz K Rotstein R et al. The erythrocyte adhesiveness/aggregation test to reveal real-time information of rheological relevance in patients with familial and primary hypercholesterolemia before and following plasma exchange. Ther Apher 2002 6 : 140 4.
24. Schechner V Berliner S Shapira I et al. Comparative analysis between dextran sulfate adsorption and direct adsorption of lipoproteins in their capability to reduce erythrocyte adhesiveness/aggregation in the peripheral blood. Ther Apher Dial 2004 8 : 39 44.
25. Berliner S Ben-Ami R Samocha-Bonet D et al. The degree of red blood cell aggregation on peripheral blood glass slides corresponds to inter-erythrocyte cohesive forces in laminar flow. Thromb Res 2004 114 : 37 44.
26. International Committee for Standardization in Hematology. Recommendation of measurement of erythrocyte sedimentation rate of human blood. Immunochemistry 1965 2 : 235 54.
27. Chen S Barshtein G Gavish B Mahler Y Yedgar S. Monitoring of red blood cell aggregability in a flow-chamber by computerized image analysis. Clin Hemorheol 1994 14 : 497 508.
28. Chen S Gavish B Zhang S Mahler Y Yedgar S. Monitoring of erythrocyte aggregate morphology under flow by computerized image analysis. Biorheology 1995 32 : 487 96.
29. Ami RB Barshtein G Zeltser D et al. Parameters of red blood cell aggregation as correlates of the inflammatory state. Am J Physiol Heart Circ Physiol 2001 280 : H1982 H1988.
30. Fabry TL. Mechanism of erythrocyte aggregation and sedimentation. Blood 1987 70 : 1572 6.
31. Rampling MW Whittingstall P Linderkamp O. The effects of fibrinogen and its plasmin degradation products on the rheology of erythrocyte suspensions. Clin Hemorheol 1984 4 : 533 43.
32. Weng X Cloutier G Genest J Jr. Contribution of the -455G/A polymorphism at the beta-fibrinogen gene to erythrocyte aggregation in patients with coronary artery disease. Thromb Haemost 1999 82 : 1406 11.
33. Martinez M Vaya A Marti R et al. Effect of HMG-CoA reductase inhibitors on red blood cell membrane lipids and haemorheological parameters, in patients affected by familial hypercholesterolemia. Haemostasis 1996 26 : 171 6.
34. Banyai S Banyai M Falger J et al. Atorvastatin improves blood rheology in patients with familial hypercholesterolemia (FH) on long term LDL apheresis treatment. Atherosclerosis 2001 159 : 513 19.
35. Weng X Cloutier G Beaulieu R Roederer GO. Influence of acute-phase proteins on erythrocyte aggregation. Am J Physiol 1996 271 : H2346 H2352.
36. Ben-Ami R Barshtein G Mardi T et al. A synergistic effect of albumin and fibrinogen on immunoglobulin-induced red blood cell aggregation. Am J Physiol Heart Circ Physiol 2003 285 : H2663 H2669.
37. Assayag EB Bornstein N Shapira I et al. Inflammation-sensitive proteins and erythrocyte aggregation atherothrombosis. Int J Cardiol 2005 98 : 271 6.
38. Klingel R Fassbender C Fassbender T Erdtracht B Berrouschot J. Rheopheresis: rheologic, functional and structural aspects. Ther Apher 2000 4 : 348 57.
39. Suckfull M. Hearing Loss Study Group. Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial. Lancet 2002 360 : 1811 17.